Literature DB >> 11682008

Chemical agents that promote chromatin compaction radiosensitize tumour cells.

S Biade1, C C Stobbe, J T Boyd, J D Chapman.   

Abstract

PURPOSE: Previous studies indicated that cells whose chromatin is naturally compacted at the time of radiation are hypersensitive to radiation-induced killing, primarily by single-hit inactivation. Some chemicals that are known to promote chromatin compaction in interphase cells are here investigated for their radiosensitizing potential.
MATERIALS AND METHODS: Okadaic acid (OA), a protein phosphatase inhibitor, fostriecin (FC), a topoisomerase II inhibitor and trichostatin A (TSA), a histone deacetylase inhibitor, were reported to promote chromatin compaction in mammalian cells. Asynchronous populations of HT-29 (human colon carcinoma) cells were exposed to various concentrations of OA, FC and TSA for various times before irradiation with various doses of Cs-137 gamma-rays and toxicity and radiosensitization were measured. Induced chromatin compaction was visualized by electron microscopy (EM). Histone 1 (H1) and histone 3 (H3) phosphorylation was measured by Western blotting, whole-cell fluorescence microscopy and confocal microscopy.
RESULTS: OA and FC produced significant radiosensitization at 2 Gy after short (2 h) exposures. These chemical treatments also produced increased phosphorylation of H3 and increased chromatin compaction as measured by EM. A 2-h exposure of cells to TSA had no effect on cell radiosensitivity, histone phosphorylation or chromatin condensation. However, a 16-h exposure to TSA produced significant radiosensitization, histone phosphorylation and chromatin condensation, presumably by secondary mechanisms.
CONCLUSIONS: These data are consistent with the hypothesis that compacted chromatin is a hypersensitive target for radiation killing. Furthermore, the modulation of chromatin conformation by drugs selectively in tumour cells might radiosensitize tumours whose cells are intrinsically radioresistant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682008     DOI: 10.1080/09553000110066068

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  14 in total

Review 1.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  Radiosensitizing effect of the histone acetyltransferase inhibitor anacardic acid on various mammalian cell lines.

Authors:  Rosemarie Ten Cate; Przemek Krawczyk; Jan Stap; Jacob A Aten; Nicolaas A P Franken
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

3.  Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.

Authors:  C Blattmann; S Oertel; M Thiemann; K J Weber; P Schmezer; O Zelezny; R Lopez Perez; A E Kulozik; J Debus; V Ehemann
Journal:  Strahlenther Onkol       Date:  2012-01-18       Impact factor: 3.621

Review 4.  Histone deacetylase inhibitor: antineoplastic agent and radiation modulator.

Authors:  Zacharoula Konsoula; Alfredo Velena; Rachel Lee; Anatoly Dritschilo; Mira Jung
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling.

Authors:  Zuoren Yu; Nicole E Willmarth; Jie Zhou; Sanjay Katiyar; Min Wang; Yang Liu; Peter A McCue; Andrew A Quong; Michael P Lisanti; Richard G Pestell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-20       Impact factor: 11.205

6.  A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cells.

Authors:  In Ah Kim; Jin Ho Kim; Jin Hee Shin; Il Han Kim; Jae Sung Kim; Hong-Gyun Wu; Eui Kyu Chie; Yong Ho Kim; Bo-Kyung Kim; Semie Hong; Seok Won Park; Sung Whan Ha; Charn Il Park
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

7.  High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones.

Authors:  Kwanghee Kim; Julianne M Pollard; Andrew J Norris; J Tyson McDonald; Yingli Sun; Ewa Micewicz; Kelly Pettijohn; Robert Damoiseaux; Keisuke S Iwamoto; James W Sayre; Brendan D Price; Richard A Gatti; William H McBride
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

8.  Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.

Authors:  George R Blumenschein; Merrill S Kies; Vassiliki A Papadimitrakopoulou; Charles Lu; Ashok J Kumar; Justin L Ricker; Judy H Chiao; Cong Chen; Stanley R Frankel
Journal:  Invest New Drugs       Date:  2007-10-25       Impact factor: 3.850

9.  Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expression.

Authors:  Yong Xu; Pritam K Sengupta; Edward Seto; Barbara D Smith
Journal:  J Biol Chem       Date:  2006-02-06       Impact factor: 5.157

10.  Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma.

Authors:  Y Shen; Y Wang; K Sheng; X Fei; Q Guo; J Larner; X Kong; Y Qiu; J Mi
Journal:  Cell Death Dis       Date:  2011-12-08       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.